This site is intended for healthcare professionals
Industry News

Menarini Group to acquire Stemline Therapeutics in transaction valued at up to $677 million and with it Elzonris.

Read time: 1 mins
Last updated:16th Mar 2021
Published:11th May 2020
Type: industry
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest